Closing Thought

Jun 01, 2015
Applied Clinical Trials
With patents for many NBCDs soon to expire, the need for regulatory guidance regarding follow-on versions of these products is crucial.
Apr 01, 2015
Applied Clinical Trials
The need for robust and standardized psychiatric outcomes measures in oncology trials has grown immensely.
Oct 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
The technology necessary to meet the expected regulatory demands for assessing drug-impaired driving has emerged.
Jun 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
Redefining this paradigm may help dispel current misperceptions around RBM and better deliver on the promise of this growing approach.
Apr 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
The prevalence of cardiovascular toxicity associated with oncology drugs has triggered a new clinical discipline that aims to promote safer drugs and better outcomes for cancer patients.
Feb 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
While capable of conducting high-quality trials, the current oversight process can be expensive and inefficient.
Dec 01, 2013
Applied Clinical Trials
Virtual CRA meetings hold a lot of potential, but work still needs to be done to ensure effectiveness.
Nov 01, 2013
Applied Clinical Trials
By Applied Clinical Trials Editors
Bring Your Own Device (BYOD) makes sense economically and socially and is the future of clinical trials.
Oct 01, 2013
Applied Clinical Trials
Expect the FDA to be looking at a new metric in the drug approval process: driving safety.
Sep 01, 2013
Applied Clinical Trials
By Applied Clinical Trials Editors
We can simultaneously establish a database that identifies signals of risk for specific product classes, and also demonstrate products that might in fact reduce risk of suicidal ideation and behavior.
native1_300x100
lorem ipsum